Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

784
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
784
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same author

A pooled analysis of phase 2 clinical trials in advanced chordoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplification.

Histopathology·2026
Same author

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Investigational new drugs·2026
Same author

Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Nature communications·2026

Related Experiment Video

Updated: Feb 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

Contemporary Sarcoma Diagnosis, Genetics, and Genomics.

Inga-Marie Schaefer1, Gregory M Cote1, Jason L Hornick1

  • 1Inga-Marie Schaefer and Jason L. Hornick, Brigham and Women's Hospital-Harvard Medical School; and Gregory M. Cote, Massachusetts General Hospital Cancer Center-Harvard Medical School, Boston, MA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|December 9, 2017
PubMed
Summary

Diagnosing rare sarcomas is challenging due to histologic overlap. Modern approaches integrate molecular and genetic analyses with traditional methods for accurate sarcoma diagnosis.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

Related Experiment Videos

Last Updated: Feb 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

Area of Science:

  • Oncology
  • Pathology
  • Molecular Genetics

Background:

  • Sarcomas are a diverse group of rare mesenchymal neoplasms with variable clinical behavior and prognosis.
  • Accurate diagnosis of sarcomas is often challenging due to histologic overlap and rarity.
  • Traditional diagnosis relied heavily on morphology and clinical presentation.

Purpose of the Study:

  • To highlight the evolution of sarcoma diagnosis over recent decades.
  • To emphasize the integration of molecular and genetic insights into contemporary diagnostic strategies.
  • To underscore the importance of combining various testing methods for accurate sarcoma evaluation.

Main Methods:

  • Incorporation of novel immunohistochemical markers as surrogates for molecular alterations.
  • Utilization of cytogenetic and molecular genetic analyses: karyotyping, FISH, RT-PCR, and targeted sequencing.
  • Correlation of diagnostic findings with clinical, radiologic, morphologic, and immunohistochemical data.

Main Results:

  • Molecular pathogenetic insights have significantly reshaped sarcoma diagnosis.
  • Genetic analyses are increasingly integral to routine sarcoma work-up.
  • Complex cases require differentiation identification and exclusion of specific genetic alterations.

Conclusions:

  • Contemporary sarcoma diagnosis integrates morphology with advanced cytogenetic, molecular, and immunohistochemical testing.
  • Understanding cancer predisposition syndromes associated with sarcomas is critical for patient and family management.
  • Accurate diagnosis requires a multidisciplinary approach, acknowledging limitations of individual tests.